Adaptin Bio (APTN) Other Non-Current Liabilities (2025 - 2026)
Adaptin Bio recorded quarterly Other Non-Current Liabilities of $551269.0 in Q1 2026, little changed quarter-over-quarter from $551269.0 in Q4 2025, and little changed year-over-year from $551269.0 in Q1 2025.
Adaptin Bio's Other Non-Current Liabilities history runs 2 years deep, the most recent figure standing at $551269.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $551269.0; the TTM figure through Mar 2026 stood at $551269.0 (changed 0.0% YoY), while the FY2025 annual figure was $551269.0, changed N/A from the prior year.
- Other Non-Current Liabilities came in at $551269.0 for Q1 2026 at Adaptin Bio, roughly flat from $551269.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $551269.0 in Q1 2025 to a low of $551269.0 in Q1 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551,269.00 |
| Dec 31, 2025 | 551,269.00 |
| Sep 30, 2025 | 551,269.00 |
| Jun 30, 2025 | 551,269.00 |
| Mar 31, 2025 | 551,269.00 |